|
NYSE Euronext (NYSE:NYX) and Deutsche Brse AG (XETRA: DB1) confirm that they have submitted revised remedies to the European Commissions Directorate-General for Competition (DG Competition). The revisions are designed to reflect the European Commissions feedback on the initial proposal, and thereby fully address the Commissions remaining concerns while preserving the industrial and economic logic of the merger. In summary, the parties have strengthened their original proposal with respect to European single equity derivatives by increasing the assets to be included in the divestiture, and to provide the purchaser of that business with an option to access Eurex Clearing for single equity derivatives products. The parties have also improved the coverage of their...
|